Patent classifications
G01N27/44726
Base sequence determination apparatus, capillary array electrophoresis apparatus, and method
A base sequence determination apparatus includes (1) a mobility correction unit that outputs a mobility correction signal obtained by mobility correction of a time-series signal of a wavelength spectrum corresponding to each base, (2) a deconvolution unit that executes processes for calculating a deconvoluted signal of the mobility correction signal respectively for a plurality of parameter candidates of point spread function, calculating variance of peak intervals for the calculated deconvoluted signal, specifying a parameter of the point spread function using the calculated variance, and outputting the deconvoluted signal corresponding to the point spread function having the specified parameter as an updated deconvoluted signal, (3) a peak extracting unit that extracts a peak waveform from the updated deconvoluted signal and outputs an updated peak-extracted signal, and (4) a sequence specifying unit that inputs the updated peak-extracted signal and determines a base sequence.
NUCLEIC ACID DETECTION KIT AND NUCLEIC ACID DETECTION DEVICE
A nucleic acid detection kit includes a kit body, a detection chip, an electrophoresis box, and a connector. The detection chip includes a channel for carrying a microbead sample of the acid. The detection chip is connected to the electrophoresis box. The connector is electrically connected to the detection chip and the electrophoresis box. The microbead undergoes a PCR amplification reaction to obtain a mixed microbead in the channel. The mixed microbead undergoes an electrophoretic detection in the electrophoresis box. A nucleic acid detection device includes the nucleic acid detection kit is also disclosed. The nucleic acid detection device has a simple structure, which is portable, flexible, and convenient, and can be used at home.
HEATING STRUCTURE, DETECTION CHIP, AND NUCLEIC ACID DETECTION DEVICE
A heating structure includes a substrate, a heating layer, a heat conducting layer, and a heat sensing layer. The heating layer includes at least one heating area. The heat conducting layer corresponds to the heating area. The heat sensing layer is disposed on the at least one heating area and electrically connected to the heating layer. The heating layer is used to heat the heat conducting layer. The heat sensing layer is used to sense a temperature of the heating area. A detection chip with the heating structure, and a nucleic acid detection device with the nucleic acid detection chip are also disclosed. The heating structure can make the heating temperature of the heating area more uniform and stable. The heating area of the heating structure has a lower heat loss and a higher heating efficiency.
NUCLEIC ACID DETECTION HOST AND NUCLEIC ACID DETECTION DEVICE
A nucleic acid detection host includes a host body, a detection kit installation area, a sample heating area, a sampling area, and an image collection unit. The detection kit installation area is configured to detachably install a nucleic acid detection kit. The sampling area is disposed above the detection kit installation area and is connected to the detection kit installation area. The sampling area is configured to add a detection solution into the nucleic acid detection kit. The image collection unit is configured to collect an image of the nucleic acid detection kit. A nucleic acid detection device including the nucleic acid detection host is also disclosed. The nucleic acid detection device has a simple structure, which is portable, flexible, and convenient, and can be used at home.
CRISPR/CAS9 IN VITRO KIT
A kit includes reagents and materials for students to make gRNA and Target DNA, cut Target DNA with Cas9 guided by the gRNA, and visualize the uncut and cut the Target DNA on an agarose gel. The kit may include a shipping box that is able to withstand transport of the reagents and materials, reagents and materials needed to perform the desired curriculum, and the curriculum necessary for using the kit. Additional curriculum may be included with extension activities as desired.
Using electrophoresis for disease detection based on controlled molecular charge
Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
USING ELECTROPHORESIS FOR DISEASE DETECTION BASED ON CONTROLLED MOLECULAR CHARGE
Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
MICROCHIP CAPILLARY ELECTROPHORESIS ASSAYS AND REAGENTS
Microchip Capillary Electrophoresis (MCE) assays and reagents to assess purity and to identify impurities in protein drug product samples are provided. Methods for analyzing analytes in a protein drug sample are provided.
USING ELECTROPHORESIS FOR DISEASE DETECTION BASED ON CONTROLLED MOLECULAR CHARGE
Electrophoresis is used to identify presence of a target compound in a patient sample based on a charge state of the compound and a label. The charge state of the compound correlates to a total net charge of a binder conjugated to the compound. The bound complex or “bound complex” with the label is then applied to the electrophoresis substrate. An electric potential is applied to the substrate for a time period and causes the labeled bound complex to migrate toward the electrode with opposite charge of the labeled bound complex at a migration velocity to form a migration pattern over the time period. At some time during or at the end of the time period, the labeled bound complex produces a bound complex band as a result of its migration across the substrate. The presence of the compound is identified based on the labeled bound complex band and one or both of the migration pattern and the migration velocity.
Systems and Methods for Mobile Device Analysis of Nucleic Acids and Proteins
One aspect of the invention provides a system for rapid analysis of biological samples. The system includes: a mobile device that receives at least one integrated chip. The mobile device processes the integrated chip to analyze a biological sample loaded thereon. The mobile device and the integrated chip together are configured to perform at least one of manipulation and control of a molecule or a fluidic system on the integrated chip. The mobile device and integrated chip together are configured to precision control at least one parameter that governs at least one of a plurality of steps of the analysis of the biological sample to within plus or minus 10%, plus or minus 1%, plus or minus 0.1%, plus or minus 0.01%, plus or minus 0.001% or plus or minus 0.0001%.